Citadel Advisors - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 24 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Citadel Advisors ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q1 2020$37,000
-65.1%
72,562
+31.8%
0.00%–
Q1 2019$106,000
+82.8%
55,034
+117.5%
0.00%–
Q4 2018$58,000
-84.3%
25,300
-53.2%
0.00%–
Q3 2018$369,000–54,044–0.00%–
 Download
Other shareholders
INNOVATE BIOPHARMACEUTICLS I shareholders Q1 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders